FcRn. We observed that FcγR binding was not required for transport and that FcRn transported less IgG2 than IgG1. Transport of IgG1 with a shortened lower hinge (ΔGly236, absent in germline IgG2), was reduced to levels equivalent to IgG2. Conversely, transport of IgG2 + Gly236 was increased to IgG1 levels. Gly236 is not a contact residue between IgG and FcRn, suggesting that its absence leads to an altered conformation of IgG, possibly due to a less flexible Fab, positioned closer to the Fc portion. This may sterically hinder FcRn binding and transport. We conclude that the lack of Gly236 is sufficient to explain the reduced FcRn-mediated IgG2 transcytosis and accounts for the low maternal/fetal IgG2 ratio at term.
significantly exceeds that found in maternal serum, with slightly less IgG4 being transported. The trans-placental transport of IgG2 and IgG3 is the least efficient, being roughly equal. [21] [22] [23] [24] [25] [26] .
Interestingly, both IgG1 and IgG2 are reported to have similar fractional catabolic rates and half-lives of 21-28 days 27, 28 , indicating that FcRn is able to rescue IgG1 and IgG2 equally efficiently from lysosomal degradation and implying that the mechanisms for transplacental transport may differ from those involved in apical recycling. In contrast, the half-life of IgG3 is approximately 7 days (comparable to that of other non-FcRn binding serum proteins), suggesting the FcRn rescuing function to be deficient for IgG3 27 . Despite this, IgG3 is transported across the placenta to a similar extent as IgG2, albeit to a lower degree than IgG1 [21] [22] [23] [24] [25] [26] . We recently demonstrated that the short half-life and lowered FcRn-meditated transcytosis of IgG3 were due to competition between different subclasses for FcRn-mediated rescue and that IgG3 was less successful due to a single amino acid difference within its FcRn-binding site. At this position (435) IgG3 has an arginine compared to histidine in other subclasses 28, 29 . Individuals with the histidine-containing allotype of IgG3 (G3m(s,t) allotype which is uncommon in Europe, but relatively common in Asia and Africa), have half-life and transport across the placenta comparable to IgG1 25, 28, 30 .
Conversely, IgG1 and IgG2 are not known to differ in their affinities for FcRn or known IgG-FcRn contact residues 6, 31 . Other FcγR might be involved in trafficking IgG across the placenta such as FcγRIIb 20 and might favour certain subclasses. However, whereas FcRn is required, the role of FcγRIIb has been excluded in the trans-placental transport of mice 32, 33 . Recently, we also found no evidence for any preference for either light chain isotype or IgG2 hinge isomer (formed by different disulphide-bridge formations between cysteines in the upper IgG2-hinge and the light chains), indicating that the difference in hinge flexibility reported by Dillon et al. 34 does not affect FcRn function 26 . We have also recently generated a IgG variant lacking Fc-receptor effector functions by engrafting IgG2-and IgG4-derived amino acids onto IgG1 (Δnab 35 ), which still binds FcRn. However, this variant showed surprisingly low FcRn-mediated transport 36 , warranting further investigation. Here we present a study on FcRn mediated IgG1 and IgG2 transcytosis and describe new findings on the differential transport of these subclasses. Our data suggest that IgG2 is transported less efficiently by FcRn due to the shorter and less flexible hinge of IgG2 than IgG1 and IgG3 34, 37 . We postulate that the shortened hinge may influence the interaction of IgG2 with FcRn dimers because of steric hindrance with the plasma membrane 6, 10 .
Materials and Methods
Cell culture. Human choriocarcinoma cells (JAR, American Type Culture Collection, Manassas, VA) were grown in Iscove's Modified Dulbecco's Medium (IMDM) (Cambrex, Verviers, Belgium), and melanoma cells (wild type A375 lacking FcRn expression (but expressing Beta-2-microglobuline (β2m)) and A375 transfected with the FcRn α-chain) 28 , in Roswell Park Memorial Institute (RPMI) 1640 medium (Invitrogen/Gibco, Carlsbad, California), both supplemented with L-glutamin (300 μg/ml, Invitrogen/Gibco), penicillin (100 U/ml, PAA Laboratories GmbH, Pasching, Germany), streptomycin (100 μg/ml, PAA) and 10% foetal calf serum (FCS, Bodinco, Alkmaar, The Netherlands). All cultures were carried out at 37 °C, in saturated humidity and 5% CO 2 in air.
Isolation of White Blood Cells (WBCs).
WBCs were isolated from 9 mL of freshly drawn blood, taken up in VACUETTE heparin blood collection tubes (Greiner Bio-one, Alphen a/d Rijn Nederland). Whole blood was separated by centrifugation at 1600 x g for 10 min, serum fraction was discarded. Red blood cells were lysed by three consecutive steps of hypotonic lysis in cell culture grade water (Gibco) for 30 sec, followed by addition of filtered (0.2 µm, Whatman) 10 x PBS. The protocol was performed at 4 °C/on ice.
Fluorescence activated cell sorter (FACs). A375 (wild-type and human FcRn) and JAR cells were treated with trypsin Ethylenediaminetetraacetic acid (EDTA) (0.5% and 0.2% (m/V)) for 5 min at culture conditions. 2 × 10 5 cells per well were added to 96 well V-bottom plate (Costar/Corning) and stained with biotinylated mouse anti human Cluster of differentiation (CD)64 (FcγRI) (BD Pharmingen), CD32 (FcγRII) (Bio-Rad) and CD16 (FcγRIII) (SouthernBiotech, Birmingham, Alabama) for 30 min at 4 °C/on ice. Cells were washed thoroughly and incubated with Alexa Fluor 633 (AF 633) conjugated Streptavidin (Thermo Scientific). FACS analysis was performed on LSR-II (BD Biosciences), data was analyzed using FlowJo v10 (FlowJo, LLC). The experiment was performed in duplicate.
IgG.
For an overview of the antibodies used in this article and the figures they were used for, see Table 1 .
Recombinant B2G antibodies directed against human platelet antigen (HPA)-1a were produced as previously described 38 . For the B2G mutants, residues in IgG1 were substituted with corresponding amino acids from IgG2 and IgG4, reported to be responsible for their low affinity for FcγR. The Δc signifies alterations of the IgG1 backbone originating from IgG2 (E233P, L234V, L235A). Δb indicates the same substitution but accompanied by deletion of G236, a residue lacking in IgG2. Δa mutations originate from IgG4 (A327G, A330S, P331S). After alteration of three more residues aimed at removing allotypic variation from IgG1 (Δn, K214T, D356E, and L358M), this resulted in two variants of IgG1: Δnab and Δnac differing only by absence or presence of G236, both demonstrating severely reduced binding to FcγR but retaining all residues described to be involved in binding to FcRn 35, 39, 40 . Production of the wild type B2G and its variants were performed as described previously.
Recombinant V-gene matched IgG1 and IgG2 GDob1 antibodies, directed against Streptococcus pneumoniae serotype 6 41, 42 , were produced in 293Freestyle cells (Invitrogen) according to the manufacturer's instructions. GDob1IgG1H435A was generated as described 42 . Likewise, GDob1IgG1Δ236 G, GDob1IgG2 + 236 G, and GDob1IgG2H435A, were generated using the Quickchange Site-directed-mutagenesis kit (Stratagene, California, USA) using the following primers and their complementary primers: www.nature.com/scientificreports www.nature.com/scientificreports/ GDob1IgG1Δ236G :5′ CCT CAG CAC CTG AAC TCC TGG G^^ ^AC CGT CAG TCT TCC TCC TCT TC 3′ GDob1IgG2 + 236G :5′ CTC TTC CTC AGC ACC ACC TGT GGC AGG AGG GCC GTC AGT CTT CCT CTT CCC CCC 3′ GDob1IgG2H435A :5′ GAG GCT CTG CAC AAC GCC TAC ACG CAG AAG AGC C 3′.
All mutations were confirmed by sequencing (ABI 373 Stretch automated sequencing machine, Applied Biosystems, Foster City, CA) prior to expression. surface plasmon resonance (spR). Human FcRn was produced in-house as described in 43 and 44 , respectively. Affinity measurements were performed with SPR using the IBIS MX96 (IBIS Technologies, Enschede, the Netherlands) as described by Dekkers et al. 45 .
Human FcRn was spotted in six duplicates with a three-fold dilution ranging from 30 nM to 1 nM on a SensEye G-streptavadin sensor (Ssens, Enschede, the Netherlands) using a Continuous Flow Microspotter (Wasatch Microfuidics, Salt Lake City, Utah)…
The GDob1 antibodies were injected in a two-fold dilution series starting from 0.49 nM to 125 nM over the FcRn-sensor in PBS-Tween 80 (0.075%) at pH 6.0. After every injection a two-step regeneration was performed using PBS pH8.5 + 0.075% Tween-80.
Calculation of the dissociation constant (KD) was done using an equilibrium analysis by intrapolation to Rmax = 1000 for FcRn 45 . Analysis and calculation of all binding data were carried out with Scrubber software version 2 (Biologic Software, Campbell, ACT, Australia) and Microsoft Office Excel 2013.
IgG transcytosis.
Transcytosis experiments with A375 (wild-type and human FcRn) and JAR cells were performed as previously described 28 . Briefly, 12 mm polycarbonate Transwell filters (0.4 μm pore size, Costar/ Corning) were inoculated with 5 × 10 5 cells, grown overnight to confluence, washed with phosphate buffered saline (PBS) and medium replaced with fresh medium (IMDM at pH 7.4 with supplements as stated above). Mixtures of IgG contained streptavidin-horseradish peroxidase (HRP) (Sanquin) to assess background transport. Apical to basolateral transport was calculated according to ([IgG]basolateral × 1.5 ml)/([IgG] input × 0.5 ml) × 100%. All experiments were performed in triplicate. serum samples. Serum samples from the umbilical cord of three newborns and matched serum samples from mothers were drawn at birth. IgG subclass levels in these samples were determined by nephelometry as described below. Signed informed consent was obtained from all women, and the collection of blood samples and clinical data received approval by the Ethics Committee of the Leiden University Medical Centre (P02-200) as has been previously reported 24 , in accordance with relevant guidelines.
IgG quantification. IgG subclass concentrations in serum samples were determined by Nephelometry
(Behringer Nephelometer II, Behringer diagnostics, Deerfield, Illinois, USA) according to manufacturer's protocols. In all in vitro studies, IgG subclasses were quantified by sandwich enzyme-linked immunosorbent assay (ELISA) using subclass specific mouse monoclonal antibodies (IgG1: MH161-1; IgG2: HP6062, Sanquin) to capture and a directly HRP conjugated monoclonal mouse anti-IgG (JDC-10, Southern Biotech, Birmingham, AL, USA) for detection. Conversion of 3,3′,5,5′-Tetramethylbenzidine (TMB) was used to quantitate HRP activity per well and absorptions were read using a Sunrise TECAN spectrophotometer. The concentrations were read from a standard curve made from the IgG preparations used for transport (in vitro studies) or IVIg.
High-Pressure Liquid Chromatography Size-exclusion chromatography (HPLC-SEC).
ÄKTA explorer P900 (GE Healthcare) equipped with Superdex 200 10/300GL (GE Healthcare) was employed for HPLC-SEC. The column was adjusted to previously degassed PBS with two column volumes prior to sample run. 100 µL of purified Ab at a concentration of 1 mg/mL was injected manually. Analysis was performed at a flow of 0.5 mL/min, detecting at UV 280 nm.
Name
Subclass mutations in the backbone specificity of CDR Used in figure   B2G1  IgG1  none  HPA-1  2   B2G1Δnab  IgG1  K214T, D356E, L358M, A327G, A330S, P331S,  E233P, L234V, L235A, deletion of G236  HPA-1  2   B2G1Δnac  IgG1  K214T, D356E, L358M, A327G, A330S, P331S 
Results
IgG2 and IgG3 are transported across the placenta to a lesser extent than IgG1 and IgG4. We analyzed three matched mother and cord sera at term. Similar to previous studies 21,23-26 , we found that only IgG1 had a higher concentration in cord blood than in maternal serum, IgG2 and IgG3 were present in lower amounts in cord blood than in maternal serum, and IgG4 concentrations were equal (Fig. 1 ).
FcRn mediated apical to basolateral IgG1 transport is more efficient than IgG2 transport in vitro. In order to analyze the relative transport of IgG1 and IgG2 and the role of FcγR and FcRn, we analyzed their transport in vitro using the choriocarcinomic JAR cells (endogenously expressing FcRn) 28 , A375 cells devoid of FcRn 28 expression, and A375-FcRn transfectants 46 . None of these cell lines expressed classical FcγR as seen by FACS ( Supplementary Fig. 1 ). As seen in vivo, we observed that IgG1 (B2G1) was transported more efficiently than IgG2 (B2G2) (an otherwise identical antibody of the IgG2 subclass) both by JAR cells ( Fig. 2A ) and A375-FcRn cells (Fig. 2B ), but not FcRn-deficient wild type A375 cells (Fig. 2C ).
IgG transcytosis is independent of the ability to bind Fcγ receptors. We have previously described B2G1Δnac, a mutated IgG1 variant with amino acids which are implicated in FcγR binding being replaced by corresponding residues found in IgG2 or IgG4. This variant displays almost no binding to activating FcγR but retains 40% binding to the inhibitory FcγRIIb 39, 47 . This mutant was transported with equal efficiency as wild type IgG1 antibody in JAR cells ( Fig. 2A ) and A375-FcRn cells (Fig. 2B ). However, another variant, B2G1Δnab, identical and with similar FcγR-binding properties as B2G1Δnac but additionally lacking glycine 236 (G236) which is absent in wild type IgG2, was transported less efficiently and to the same extent as the wild type IgG2 molecule (B2G2) ( Fig. 2A,B ). This was observed in both JAR ( Fig. 2A ) and A375-FcRn cells (Fig. 2B ) but no significant transport was found in wild type (WT)A375 cells lacking FcRn and FcγRs expression 28 (Fig. 2C) . These findings demonstrated that FcRn, and not classical FcγR, was required for transcytosis of IgG in both JAR and A375 cells and suggested that absence of G236 may reduce the efficiency of this transcytosis.
Apical to basolateral transcytosis of IgG is influenced by glycine 236. To ascertain whether
the reduced IgG2 transport was due to the lack of G236 compared to IgG1, we generated recombinant antibodies differing only in this single amino acid. Affinity measurements by SPR with c-terminally biotinylated FcRn on streptavidin sensors showed that either removing G236 from IgG1 or introducing it into IgG2, did not apparently influence binding to FcRn on the chip (Fig. 3) . The wild-type and mutant GDob1 antibodies displayed a similar minor fraction of dimers which was similar across all variants ( Supplementary Fig. 2 ), also seen in rather steep associations and slow disassociation in Fig. 3 . We found that IgG1 lacking only G236 (GDob1IgG1ΔG236) was transported to an equal level as wild type IgG2 (Fig. 4A) . Moreover, IgG2 with G236 inserted (GDob1IgG2 + G236) demonstrated enhanced transport and was transported to an equal level as wild www.nature.com/scientificreports www.nature.com/scientificreports/ type IgG1, confirming that the lack of G236 in IgG resulted in its less efficient FcRn-mediated transcytosis. When the affinity of the primary binding site of IgG for FcRn was strongly reduced by changing the histidine in position 435 to an alanine (H435A) 48,49 significant transport was still observed, but it was severely reduced as expected. Importantly, no significant difference between IgG1 and IgG2 transport was observed when both carried the H435A mutation, suggesting FcRn-mediated effector functions were responsible for the observed differences All experiments were run for two hours and transport was from the apical to the basolateral side of a monolayer of cells. HRP was included as a measure of aspecific leakage and measured in the same samples as IgG. All data are from 3 independent experiments, expressed as mean plus standard deviation. Data was analysed by one-way ANOVA with Tukey's multiple comparison test and significance is shown as previously indicated www.nature.com/scientificreports www.nature.com/scientificreports/ in IgG1 and IgG2 transport efficiency. In addition, role of FcγR can be excluded by their absence in these cells (Supplemental Fig. 1 ).
Reduced FcRn mediated transport correlates with enhanced degradation. To investigate whether
the reduced transcytosis rates of IgG without G236 were due to increased degradation, we sampled both apical and basolateral compartments after 18 hours of transport.
For both wild type GDob1IgG1 and GDob1IgG2 + G236 the total amounts detected were in excess of 95% of the starting material, while wild type GDob1IgG2 and GDob1IgG1ΔG236 were recoverable to a significantly lesser extent (Fig. 4B ). This suggested that the reduced FcRn-mediated transcytosis of GDob1IgG2 and GDob1IgG1ΔG236 (Figs 1-2 ) was due to enhanced degradation.
Discussion
The long half-life of IgG and its transplacental transport are both mediated by the neonatal Fc receptor 5, 19, 23 . FcRn-mediated half-life of IgG2 is comparable to that of IgG1 27 but transport across the human placenta is lower for IgG2 [21] [22] [23] [24] [25] [26] , suggesting differences between the mechanisms of FcRn-mediated recycling and transcytosis of IgG. The reason for this is unclear, as IgG1 and IgG2 have not been reported to differ in residues found to be important for IgG-FcRn interaction 6 and their binding to FcRn immobilized on a biosensor chip were not reported to be significantly different 31 . However, the stoichiometry 10 , the lateral fluidity of transmembrane receptors, and the physiological proximity of the plasma membrane cannot be accounted for on a surface like plasmon resonance biosensor chips, and therefore, such assays do not always accurately represent the biological context.
The lowered in vitro FcRn-mediated transcytosis rates of IgG2 compared to IgG1 which we observed were in line with the reported differences in maternal-cord blood ratios. This difference was solely attributed to FcRn-mediated transcytosis as transcytosis of B2G1Δnac, an IgG1 variant unable to bind to classical FcγR 38, 39, 47 , was unaffected in both JAR and A375-FcRn cells. Unexpectedly, the transcytosis rate of another IgG1 variant, B2G1Δnab, was reduced to the level of IgG2 transcytosis. The only difference between the Δnac and Δnab variants was the deletion of G236 in the latter, similar to IgG2 that also lacks G236. Using unrelated human IgG1 and IgG2 V H -matched GDob1 antibodies 41, 42 with identical affinity for FcRn in SPR experiments, we confirmed that G236, but not any other mutations in B2G1Δnac or B2G1Δnab, influenced the transport of IgG. Interestingly, G236 has not previously been reported to affect FcRn function and is located in the lower hinge, far from the FcRn binding site 6 (Fig. 5) .
Gurbuxani et al. postulated a mathematical model for FcRn-IgG interaction 50, 51 , in which either FcRn can bind to IgG in two distinct modes, or IgG might have two FcRn binding sites, functioning synergistically. Whether such a secondary interaction-domain within IgG exists is unclear, but it cannot be excluded as a cocrystal of a complete IgG-FcRn complex has not yet been resolved. Björkman and colleagues observed an FcRn dimer both in crystals of rat FcRn and in the cocrystal of FcRn with Fc 6, 49 . Later work demonstrated that Fc and FcRn can crystallize in oligomeric ribbons with a symmetrical repeating unit of 2 FcRn:1 IgG (FcRn:IgG:FcRn) with the C-terminus of IgG orientated towards the N-terminus of FcRn 52 . Both the proposed "lying down" or "standing up" models for FcRn engaged with IgG binding have difficulties explaining how a complete IgG binds to FcRn in a cellular context. In the "standing up" model the two Fab fragments would be projected to either protrude into the plasma membrane, or, due to the flexibility of the hinge, bend back (Fig. 5A ). The fragment antigen binding (Fab) might be more easily accommodated if FcRn is tilted towards the cell but some bending at the hinge would still be required (Fig. 5B) . The binding of a second FcRn to this complex, forming a 2:1 complex of FcRn and IgG which might be important for FcRn-signalling events 16 , may occur within the IgG/FcRn positive-transport tubules observed by the groups of Ober and Ward et al. 53, 54 . Within these tubules one molecule of IgG may be bound by two FcRn molecules residing in a tilted orientation on parallel membranes. This is similar to what was suggested to occur between adjacent microvilli in the rodent gut by Bjorkman et al. 6 , who observed by electron cryotomography that IgG-Fc complexes assemble preferentially on interfaces between layers of FcRn expressing membranes 54, 55 . Whether this "laying down" model, the "standing up" model or both is more relevant for physical transport of IgG is currently unknown. www.nature.com/scientificreports www.nature.com/scientificreports/ G236 is present in the lower hinge of all subclasses except IgG2, and increases the flexibility and extends the distance of the two Fab domains from the Fc portion. Based on the structural constraints for binding of whole IgG by FcRn, and the findings presented here, we predict that the shortened hinge of IgG2 makes the formation of an FcRn:IgG2:FcRn complex less energetically favourable than is the case for other IgG and thus decreases the compatibility of IgG2 with FcRn binding and transport. This is supported by recent evidence showing that the amino-acid composition of the Fab fragment and charge in particular effects FcRn binding and recycling 56 . Our study may in part provide a solution as to why IgG2 transcytosis takes place at a lower rate than IgG1. Approximately 95% of GDob1IgG1 and GDob1IgG2 + G236 could be accounted for, while only about 80% of GDob1IgG1Δ236Gly and GDob1IgG2 was detectable. Data shown are from three independent experiments, expressed as mean plus standard deviations. In B) the total values from apical and basolateral samples taken from the same transwells. Significance was tested by one way ANOVA with Tukeys multiple comparisons test in both (A,B). In (A) statistical comparison within an IgG subclass is shown without brackets and only shown for comparison with the WT variant, but between subclasses (with brackets) only shown for WT subclasses, G236 inserted in IgG2 and G236 removed from IgG1, and matched for the presence or absence of G236 IgG1 and IgG2 variants.
www.nature.com/scientificreports www.nature.com/scientificreports/ However, it does not explain why in vivo rates of IgG2 and IgG1 catabolism do not seem to differ, unless these two FcRn-mediated processes fundamentally differ, or hitherto unknown factors make IgG2 less prone to degradation, compensating for the reduced FcRn rescue function. This last option is however entirely speculative and we are not aware of any data indicating that this is the case.
In summary, we show that the lowered transplacental transport of IgG2 in vivo can be simulated in an in vitro transcytosis system, is FcRn-but not FcγR-mediated, and is caused by the absence of G236 in IgG2. More effort is needed to unravel the cellular mechanism behind the observation that the short lower hinge of IgG2 affects transcytosis but not its half-life. 
